相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
Mikkael A. Sekeres et al.
LEUKEMIA (2021)
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors
Noboru Yamamoto et al.
INVESTIGATIONAL NEW DRUGS (2021)
Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold
Chaodong Xiong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma
Angela McHugh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells
Xiaochen Zhou et al.
NEOPLASIA (2020)
NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression
Sanoj K. Naik et al.
CELL DEATH & DISEASE (2020)
Increased PARP1-DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1-DNA trapping is correlated with PARP1 inhibitor's cytotoxicity
Hua-Dong Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Chihoko Yoshimura et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
Ronan T. Swords et al.
BLOOD (2018)
A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification
Bo Xu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor
Xiaoyu Chen et al.
CELL CYCLE (2018)
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Gabriele Picco et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Gabriele Picco et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine
Hua Li et al.
NEOPLASIA (2017)
MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma
Shuai Tong et al.
SCIENTIFIC REPORTS (2017)
Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma
Jiyou Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials
Bo Yuan et al.
CANCER LETTERS (2017)
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors
John Sarantopoulos et al.
CLINICAL CANCER RESEARCH (2016)
MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors
K. L. B. Knorr et al.
CELL DEATH AND DIFFERENTIATION (2015)
Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma
Yi-Lin Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
SCF ubiquitin ligase-targeted therapies
Jeffrey R. Skaar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924
Amir A. Jazaeri et al.
MOLECULAR CANCER THERAPEUTICS (2013)
HECT and RING finger families of E3 ubiquitin ligases at a glance
Meredith B. Metzger et al.
JOURNAL OF CELL SCIENCE (2012)
SCF E3 Ubiquitin Ligases as Anticancer Targets
L. Jia et al.
CURRENT CANCER DRUG TARGETS (2011)
Mechanistic Studies of Substrate-assisted Inhibition of Ubiquitin-activating Enzyme by Adenosine Sulfamate Analogues
Jesse J. Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Stereoselective Synthesis of MLN4924, an Inhibitor of NEDD8-Activating Enzyme
Hyuk Woo Lee et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity
Julie L. Lukkarila et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
Ronan T. Swords et al.
BLOOD (2010)
NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
Jie Jessie Lin et al.
CANCER RESEARCH (2010)
Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer
Teresa A. Soucy et al.
CLINICAL CANCER RESEARCH (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Structural insights into NEDD8 activation of Cullin-RING ligases: Conformational control of conjugation
David M. Duda et al.
CELL (2008)
Multimodal Activation of the Ubiquitin Ligase SCF by Nedd8 Conjugation
Anjanabha Saha et al.
MOLECULAR CELL (2008)
DDB1 maintains genome integrity through regulation of Cdt1
Courtney A. Lovejoy et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The discovery of ubiquitin-dependent proteolysis
KD Wilkinson
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Nedd8 on cullin: building an expressway to protein destruction
ZQ Pan et al.
ONCOGENE (2004)
Conservation in the mechanism of nedd8 activation by the human AppBp1-Uba3 heterodimer
RN Bohnsack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8
H Walden et al.
NATURE (2003)
NEDD8 recruits E2-ubiquitin to SCF E3 ligase
T Kawakami et al.
EMBO JOURNAL (2001)
分享论文
